# Use of Corifolitropin Alfa in Oocyte Donors

> **NCT02213627** · PHASE4 · UNKNOWN · sponsor: **IVI Madrid** · enrollment: 300 (estimated)

## Conditions studied

- Female Reproductive Problem
- Infertility

## Interventions

- **DRUG:** Corifollitropin alfa
- **DRUG:** Recombinant FSH
- **DRUG:** HP-hMG

## Key facts

- **NCT ID:** NCT02213627
- **Lead sponsor:** IVI Madrid
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2015-09
- **Final completion:** 2015-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2015-07-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02213627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02213627, "Use of Corifolitropin Alfa in Oocyte Donors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02213627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*